Eligo Bioscience is a biotech company developing a new generation of antibiotics, called “eligobiotics”.
Eligo Bioscience is a biotech company developing a new generation of antibiotics, called “eligobiotics”.
Nabriva Therapeutics is a biopharma company developing a new class of antibiotics (pleuromutilins) for the treatment of patients with serious infections caused by multi-drug resistant pathogens.
As specialists in innate immunology, InvivoGen is a global leader of resources for the next breakthroughs in this field. Unparalleled skill in microbial fermentation enables InvivoGen to provide a wide range of biological molecules, including novel mycoplasma treatments, ultra-pure antibiotics and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.